comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 12:17:43 - browse：4

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Wayne Brady comes out as pansexual: 'Free to love whomever I want'

hotspot

WSS

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Adam's Biotech Scorecard: Do Sarepta's exon

Heat waves linked to early deliveries, preterm births in new study

Do more moles mean more problems? Not so, says new study

What will save rural psychiatry services? Higher Medicaid payments

Stigma and the return of syphilis

hotspot

comprehensive

focus

Hollywood unions extend contract negotiations for actors

The best solution to the drug shortages problem

Malaria cases in Florida and Texas: Here’s what you need to know

Health insurers say they are turning to AI to cut costs, improve care

At least 13 dead in Texas as scorching temps continue

NIH trials fail to test meaningful long Covid therapies, experts say

BioMarin wins approval for gene therapy to treat hemophilia A

Dark money group runs ads on China biotech bill

Affirmative action in medical school literally saved lives

NIH trials fail to test meaningful long Covid therapies, experts say

focus

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

David Sabatini, ex

NIH trials fail to test meaningful long Covid therapies, experts say

Report: NIH

How to use technology to prevent future drug shortages

A biotech analyst on neuroscience, placebo effect, not over

hotspot

leisure time

entertainment

hotspot